QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.

catalona waters

Dr. Catalona Discusses Nerve-Sparing Surgery

Defining a nerve-sparing radical prostatectomy is easy: During the surgical removal of the prostate gland, an attempt is made to spare the two cavernous nerve sheaths (lying slightly underneath and to the sides of the gland) that produce erections. Completing…

Read More

PSA Study: Medical Specifications of Prostate Cancer

This article discusses medical specifications of prostate cancer: clinical stage, PSA reading, DRE findings, number and percentage of cancer in biopsy cores, and Gleason score. It answers the questions: What do I do with these terms of the specification of…

Read More
Catalona torre

PSA Study: Markers for Prostate Cancer: What’s New

New findings are improving the screening procedures for prostate cancer. This article is based upon a State-of-the-Art Presentation given by Dr. Catalona at the American Urological Association Annual Meeting this May. The genetics revolution will change the way prostate cancer…

Read More

Nerve-sparing RRP Preserves Potency and Continence

Nerve-sparing RRP (radical prostatectomy) can result in preserving potency and continence with a low complication rate. Complications can be reduced with increasing surgeon experience. The June 19 Wall Street Journal contained an article on nerve-sparing radical prostatectomy. Information included six…

Read More
spr2002 article2

Key to High Cure Rate Is Early Diagnosis

“We should be able to cure 90% of prostate cancer with early detection and appropriate treatment recommendations.” The key to good results in treating localized prostate cancer is to make the diagnosis as early as possible. Now, at least 80%…

Read More

Early Treatment Options for Prostate Cancer

Different treatment options allow for more success in early treatment of localized prostate cancer. “Watchful Waiting” The most conservative, least invasive treatment for prostate cancer is so-called “watchful waiting,” which also includes dietary therapy. Watchful waiting is only safe for…

Read More

Subscribe to Quest

"*" indicates required fields


This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*